Skip to content

Concurrent maternal stress and THC exposure during pregnancy alters adolescent behavioral outcomes and corticolimbic molecular programs.

Jimmy Olusakin, Mahima Dewan, Atul Kashyap, Daniela Franco, Gautam Kumar, Miguel A Lujan, Katrina S. Mark, Joseph Cheer, Mary Kay Lobo

bioRxiv : the preprint server for biology June 28, 2025 preprint DOI: 10.1101/2025.06.26.661775 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Translational rodent model
Population Pregnant C57BL/6 mice and their adolescent offspring
Interventions THC maternal witness defeat stress
Dose 2 mg/kg
Duration Gestational day 3-12 for stress exposure; THC daily from GD3 until birth; outcomes measured in adolescence
Topics Cannabis
Keywords Maternal stress Nucleus accumbens Adolescents Prefrontal cortex
Key points Prenatal THC and stress independently and additively impair maternal behavior and produce lasting sex- and region-specific gene expression changes in the prefrontal cortex and nucleus accumbens of adolescent offspring.

Abstract

Cannabis use during pregnancy is increasing, often to alleviate stress and anxiety, yet the long-term effect of prenatal cannabis exposure alone or in combination with psychosocial stress on offspring neurodevelopment or maternal behaviors remains unclear. Here, we developed a translational rodent model combining prenatal Δ9-tetrahydrocannabinol (THC) exposure with chronic psychosocial stress using the maternal witness defeat stress (MWDS) paradigm. Pregnant C57BL/6 mice were exposed to MWDS from gestational day (GD) 3-12 and received daily subcutaneous THC (2 mg/kg) or vehicle until birth. All exposure groups showed impaired maternal behavior, with negative postnatal outcomes and caregiving, with additive effects observed in the combined exposure group. In adolescence, male and female offspring exhibited exposure-specific behavioral alterations. Prenatal stress and combined exposures led to increased anxiety-like behavior and reduced motivated behavior in both sexes, while THC alone primarily impacted female self-care and social behavior. Transcriptomic profiling of the prefrontal cortex (PFC) and nucleus accumbens (NAc) of adolescent offspring revealed sex- and region-specific gene expression changes across all exposure groups. Prenatal THC-, stress-, and combined exposures each altered distinct molecular pathways related to mitochondrial function, synaptic organization, and glial signaling. Comparative analysis with a perinatal fentanyl model revealed shared transcriptional substrates involved in synaptic signaling and circadian regulation. These findings indicate that THC and stress independently and additively impair maternal behaviors with lasting neurodevelopment signatures in offspring.

Comparable studies

Other preclinical and animal studies on cannabis, most cited first.

Study Year Design Participants
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors Mice 2015 Preclinical study
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). hMDR1- and hBCRP-transfected HEK293 cells and hMDR1- and hBCRP-MDCKII cells 2010 In vitro study
Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure Mice prenatally exposed to THC, including conditional CB1R knockout mice 2020 Animal experimental study
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway Mice exposed to chronic THC early in life 2018 Animal experimental study
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain Spontaneously hypertensive rats (SHRs) and Wistar rats 2014 Animal experimental study

Citations in the library

Explore topics